Healthcare & Insurance
Avinger Announces Proposed Underwritten Public Offering of Common Stock
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the
Wednesday, August 21, 2019
Roxadustat Approved in China for Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
SAN FRANCISCO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN) today announced that the National Medical Products Administration (NMPA) in China has approved expansion of the marketing authorization of roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase
Wednesday, August 21, 2019
Inspire Medical Systems, Inc. to Present at 2019 Wells Fargo Healthcare Conference
Company will also Participate in Investor Meetings at Dougherty & Company 2019 Institutional Investor ConferenceMINNEAPOLIS, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of
Wednesday, August 21, 2019
Bellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private Placement
Closing of $57.5 Million Public Offering of Preferred Stock and Warrants and Receipt of $12.1 Million Option Fee Related to Private Placement of up to $70.0 Million of Preferred Stock and WarrantsHOUSTON, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in
Wednesday, August 21, 2019
Indus Holdings, Inc. Reports Record Revenue in the Second Quarter 2019 Financial Results
Cannabis leader reports revenue of $9.7 million, representing 183% revenue growth year-over-yearSALINAS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically integrated cannabis company, today announced its financial results for the fiscal
Wednesday, August 21, 2019
Integra LifeSciences to participate in the Wells Fargo 2019 Healthcare Conference and the Morgan Stanley 17th Annual Global Healthcare Conference in
PLAINSBORO, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 5, 2019 at 1:55 p.m. ET, Glenn Coleman, chief
Wednesday, August 21, 2019
Hallmark Financial Executives to Participate in the 2019 KBW Insurance Conference
DALLAS, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Hallmark Financial Services, Inc. (“Hallmark Financial”) (NASDAQ: HALL), a specialty property and casualty insurance company, today announced that Naveen Anand, Hallmark Financial’s President & Chief Executive Officer, will speak at the 2019 KBW
Wednesday, August 21, 2019
GN Audio upgrades financial guidance for 2019
The organic revenue growth guidance for GN Audio is upgraded from “more than 19%” to “around 24%”. All other guidance parameters are unchanged. The upgraded financial guidance for 2019 is: Financial guidance 2019GN HearingGN AudioGN Store NordOrganic revenue growth~7%~24% (before
Wednesday, August 21, 2019
Publication of statement from the board of directors in respect of the takeover offer made by Nordic Transport Group Holding A/S
Company Announcement 21 August 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS OF SUCH JURISDICTION. Publication of statement from the board of directors in respect
Wednesday, August 21, 2019
NeuroSearch A/S – H1 report 2019
Announcement 21 August 2019 Below please find the H1 report 2019. The full report is available in the enclosed PDF file. NeuroSearch posted an operating loss of DKK 6.1 million in H1 2019 (H1 2018: a loss of DKK 2.8 million). NeuroSearch posted a net loss of DKK 6.3
Wednesday, August 21, 2019
Stryker to participate in Morgan Stanley 17th Annual Global Healthcare Conference
Kalamazoo, Michigan, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) ) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company
Wednesday, August 21, 2019
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will present at two upcoming investor healthcare conferences. Management will deliver a company presentation at the Baird 2019 Global Healthcare Conference
Wednesday, August 21, 2019
Oxford Immunotec to Participate in Two Upcoming Investor Conferences
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), or the Company, a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial
Wednesday, August 21, 2019
ViroGates Releases Second Quarter 2019 Results
Company announcement no. 10-2019 Birkerød, 21 August 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for the second quarter 2019 (1 April – 30 June). Highlights in the second
Wednesday, August 21, 2019
Constellation Pharmaceuticals to Participate in Two Investor Conferences
CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in two investor
Wednesday, August 21, 2019
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the presentation of preclinical data on its novel NMDA receptor
Wednesday, August 21, 2019
Invitation to Q2 conference call
Oslo, Norway, 21 August 2019 Vistin Pharma ASA will release its second quarter 2019 results on Thursday 29 August, 2019. Vistin Pharma will host a conference call for all shareholders and interested parties on 29 August at 08:00 CEST. There will be a Q&A session following the
Wednesday, August 21, 2019
Shockwave Medical to Participate in Upcoming Investor Conferences
SANTA CLARA, Calif. , Aug. 21, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced the company will be participating in two
Wednesday, August 21, 2019
MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy
Topline Results Expected in Mid-2020SOUTH SAN FRANCISCO, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that it has dosed the first subjects in a Phase 1 clinical study of MYK-224, a small molecule candidate being developed for the treatment of
Wednesday, August 21, 2019
Golden Leaf Holdings to Report Fiscal Second Quarter Earnings
TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized brands, has announced that it will report its financial results for the
Wednesday, August 21, 2019
